Jiangsu CoWin Biotech Co., Ltd. (688426.SS)

18.66 +0.60 (+3.32%) At close: 03:00PM CST

Jiangsu CoWin Biotech Co., Ltd.

No. 18, Zelan Road
Pharmaceutical High-tech Zone
Taizhou 225311
China
86 523 8620 1353
https://www.cwbio.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 657

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Zhihua Zhuang	Deputy GM & Director	N/A	N/A	1981
Mr. Yubai Qi	Deputy GM, Board Secretary & Director	N/A	N/A	1981
Mr. Fu Gang Li	Deputy GM & CFO	N/A	N/A	1977

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Jiangsu CoWin Biotech Co., Ltd. engages in the research and development, production, and sale of biological products in China. The company provides molecular diagnostic raw material enzymes, nucleic acid collection and protection agents, nucleic acid extraction and purification kits, molecular diagnostic testing reagents, etc. It also offers medical device products, nucleic acid collection and protection, PCR, RT-PCR, and qPCR products, molecular diagnosis, isothermal amplification, nucleic acid mass spectrometry, next generation sequencing, nucleic acid extraction and purification, marker clone transfection, antibody, protein detection products, and scientific research instruments. The company was founded in 2010 and is headquartered in Taizhou, China.

Corporate governance

Jiangsu CoWin Biotech Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.